Draft Bill Aims To Clarify FDA Regulation Of Mobile Medical Apps
This article was originally published in The Gray Sheet
Executive Summary
Draft legislation obtained by “The Gray Sheet” that seeks to restrain FDA’s oversight of mobile apps is being circulated for stakeholder comment by Rep. Marsha Blackburn, R-Tenn., and colleagues.
You may also be interested in...
US Midterms: Industry Loses Some Supporters In Congress, But Retains Many
With most of the Nov. 6 election tally completed, it’s clear there will be many new faces for the device industry to engage with in the halls of Congress, but the sector still appears to have a significant group of supporters on Capitol Hill. Also, several medtech-relevant measures were on the ballot.
Voters Likely To Pick And Choose Among Device Industry Favorites In Close Races
Among the very tight Republican and Democrat contests anticipated in this November’s US midterm elections are more than a few device industry-favored candidates, according to a review of the incumbents’ voting records and recent polling data.
'Cures' Bill Circumvents FDA On Medical Software Regs
Lobbyists for the medical software industry, and particularly clinical decision support tools are "delighted" that lawmakers are getting around the agency by explicitly stating the types of software it is not allowed to regulate in the 21st Century Cures Act, set to pass Congress by the end of the year.